ITGAM and interstitial lung disease: Therefore, OS might alleviate RA‐ILD by mitigating the aggregation of CD11b+ macrophages in lungs of CIA models and downregulating systemic inflammation, further suggesting OS as a drug candidate,55, 56, 57 which might be beneficial to the treatment of RA‐ILD.